Published in Health and Medicine Week, August 2nd, 2004
Under the agreement Sirenade will perform structural biology services related to an undisclosed target protein provided by Solvay. The work to be performed will range from cloning and expression of Solvay's target protein to the characterization of its structure. Sirenade will also provide Solvay with co-crystal structures of the target protein in complex with Solvay's compounds.
Sirenade will receive service payments and additional payments are possible upon reaching certain milestones. Sirenade has used its...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.